Read More
Night Recap - November 16, 2026
2 mins ago
Reuters releases more intimate photos of Jensen Huang and Alice Huang
15-11-2026 01:46 HKT




The US Food and Drug Administration (FDA) has issued its highest-level alert about a heart pump that has been linked to 49 deaths and 129 injuries. The concerned medical device is also used in Hong Kong.
The Impella left sided pumps are used to temporarily support a patient's heart during high-risk procedures or after a severe heart attack. However, the FDA warned that it could puncture a wall in the heart's left ventricle if used incorrectly.
The pump has a catheter with a small hook at the end, which is threaded through the blood vessels and in to the left ventricle - a key chamber in the heart used to pump blood full of oxygen around the body.
The device's manufacturer, Abiomed, has issued new instructions for the pump.
Cardiologists in the city said the device is mainly used for patients in extreme or critical conditions, and the brand involved has the largest global market share.
A summary posted on the FDA's website on 21 March classified the move as "most serious type of recall" because of the risk of serious injuries or death if the device is used incorrectly.
The agency warned that the use of affected pumps may also cause serious adverse health consequences, including "hypertension, lack of blood flow, and death".
The notice relates to 66,390 devices that were distributed in the US over two years starting from 10 October 2021. The device was given FDA approval in 2008.
A spokesperson for Johnson & Johnson - which acquired Abiomed in 2022 - told Reuters: "This notification is not a device removal and Impella heart pumps remain on the market and available for patients."
Abiomed first disclosed the risk of heart perforation during insertion of the pumps in a technical bulletin posted in October 2021, but did not share this information with the FDA at the time, the agency said.
(Staff reporter, BBC and Reuters)
